amnion-chorion membrane for Postoperative Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Postoperative Pain+1 Moreamnion-chorion membrane - Biological
Eligibility
18 - 85
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the healing of the palatal donor site when an allograft membrane is used versus when no allograft membrane is used.

Eligible Conditions
  • Postoperative Pain
  • Gum Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 60 days

60 days
Pain Catastrophizing Scale (PCS)
Pain management (medication usage)
Patient satisfaction as evaluated by Visual Analogue Scale
Postoperative pain as evaluated by subjects using the Visual Analogue Scale
Wound volumetric changes
• Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference - Short Form 8a

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Sutures
1 of 2
Allograft and Sutures
1 of 2

Active Control

Experimental Treatment

10 Total Participants · 2 Treatment Groups

Primary Treatment: amnion-chorion membrane · No Placebo Group · N/A

Allograft and Sutures
Biological
Experimental Group · 1 Intervention: amnion-chorion membrane · Intervention Types: Biological
Sutures
Procedure
ActiveComparator Group · 1 Intervention: Sutures · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 60 days

Who is running the clinical trial?

Harvard Medical SchoolLead Sponsor
29 Previous Clinical Trials
41,519 Total Patients Enrolled
Harvard Medical School (HMS and HSDM)Lead Sponsor
175 Previous Clinical Trials
1,293,951 Total Patients Enrolled

Eligibility Criteria

Age 18 - 85 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: